Related references
Note: Only part of the references are listed.SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal- like and triple-negative breast cancer
Fatimah Matalkah et al.
BREAST CANCER RESEARCH (2016)
Shp2 signaling suppresses senescence in PyMT-induced mammary gland cancer in mice
Linxiang Lan et al.
EMBO JOURNAL (2015)
Clinicopathologic Characteristics of Breast Cancer Stem Cells Identified on the Basis of Aldehyde Dehydrogenase 1 Expression
Yoon Seok Kim et al.
JOURNAL OF BREAST CANCER (2014)
HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials
Susan Dent et al.
CANCER TREATMENT REVIEWS (2013)
Src homology phosphotyrosyl phosphatase-2 expression is an independent negative prognostic factor in human breast cancer
Simone Muenst et al.
HISTOPATHOLOGY (2013)
The Tyrosine Phosphatase SHP2 Regulates Focal Adhesion Kinase to Promote EGF-Induced Lamellipodia Persistence and Cell Migration
Zachary R. Hartman et al.
MOLECULAR CANCER RESEARCH (2013)
HER2 stabilizes EGFR and itself by altering autophosphorylation patterns in a manner that overcomes regulatory mechanisms and promotes proliferative and transformation signaling
Z. Hartman et al.
ONCOGENE (2013)
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Transcriptional Control of the ERBB2 Amplicon by ERRα and PGC-1β Promotes Mammary Gland Tumorigenesis
Genevieve Deblois et al.
CANCER RESEARCH (2010)
Direct binding of Grb2 SH3 domain to FGFR2 regulates SHP2 function
Zamal Ahmed et al.
CELLULAR SIGNALLING (2010)
Molecular Mechanism for SHP2 in Promoting HER2-induced Signaling and Transformation
Xiangdong Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Inhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cells
X-D Zhou et al.
CELL DEATH AND DIFFERENTIATION (2008)
SHP2 is up-regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis
X. Zhou et al.
HISTOPATHOLOGY (2008)
Conditional deletion of Shp2 in the mammary gland leads to impaired lobulo-alveolar outgrowth and attenuated Stat5 activation
Yuehai Ke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Modulation of α-catenin Tyr phosphorylation by SHP2 positively effects cell transformation induced by the constitutively active FGFR3
J. Burks et al.
ONCOGENE (2006)
SHP-2 activates signaling of the nuclear factor of activated T cells to promote skeletal muscle growth
Mara Fornaro et al.
JOURNAL OF CELL BIOLOGY (2006)
A role for the scaffolding adapter GAB2 in breast cancer
M Bentires-Alj et al.
NATURE MEDICINE (2006)
Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling
YM Agazie et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation
T Holbro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures
J Debnath et al.
METHODS (2003)
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
G Dontu et al.
GENES & DEVELOPMENT (2003)
The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors
TPJ Garrett et al.
MOLECULAR CELL (2003)
Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor α
TPJ Garrett et al.
CELL (2002)
Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains
H Ogiso et al.
CELL (2002)
ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini
SK Muthuswamy et al.
NATURE CELL BIOLOGY (2001)
Share Paper
